INO Stock Summary and Trading Ideas (Inovio Pharmaceuticals | NASDAQ:INO)

Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Inovio Pharmaceuticals trades on the NASDAQ stock market under the symbol INO.

As of March 13, 2026, INO stock price declined to $1.66 with 900,770 million shares trading.

INO has a beta of 1.11, meaning it tends to be more sensitive to market movements. INO has a correlation of 0.05 to the broad based SPY ETF.

INO has a market cap of $114.05 million. This is considered a Micro Cap stock.

Last quarter Inovio Pharmaceuticals reported $0 in Revenue and -$.26 earnings per share. This fell short of revenue expectation by $-20,000 and exceeded earnings estimates by $.09.

In the last 3 years, INO traded as high as $14.75 and as low as $1.30.

The top ETF exchange traded funds that INO belongs to (by Net Assets): VTI, VXF, IWC.

INO has underperformed the market in the last year with a price return of -14.0% while the SPY ETF gained +21.4%. INO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -19.4% and -8.3%, respectively, while the SPY returned -2.6% and -3.5%, respectively.

INO support price is $1.62 and resistance is $1.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INO shares will trade within this expected range on the day.